CRP and metabolic syndrome: CRP is becoming a clinical marker for many noncommunicable diseases (atherosclerosis, CVD, ischemic stroke, hypertension, insulin resistance, and metabolic syndrome) and can independently predict adverse cardiovascular events in individuals, including ischemic stroke, myocardial infarction and sudden cardiac death [53].